Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?

Wednesday, Altimmune Inc ALT said the body composition study of pemvidutide showed lean mass preservation, with 25.5% of weight loss derived from lean mass with 74.5% of weight loss from adipose tissue, comparable to the effects historically associated with diet and exercise. Altimmune will…#altimmuneincalt #altimmune #phase2 #pemvidutide #metabolic #kerrisdalecapital #glp1 #bhvn #vladcoric #obese
Source: Reuters: Health - Category: Consumer Health News Source Type: news